About this trial
The goal of this clinical trial is to learn if the administration of oxycodone for preventive analgesia works to reduce the chronification of acute postoperative pain in adult participants undergoing major abdominal surgery. The main question it aims to answer is:
• Does administration of oxycodone before surgical incision reduce the occurrence of chronic pain or relieve the chronic pain symptoms 3 months after the operation? Researchers will compare oxycodone + parecoxib sodium to placebo + parecoxib sodium combinations to see if oxycodone works to reduce the chronification of acute postoperative pain.
Participants will:
* Take oxycodone + parecoxib sodium or placebo + parecoxib sodium combinations before the surgical incision * Cooperate with the follow-up staffs and complete some checkups or tests within 3 months after the operation.
Eligibility criteria
Qualifiers
ASA I~III;
BMI ranging from 18 to 28 kg/m²;
For elective laparoscopic-assisted major abdominal surgery under general anesthesia;
Estimated surgical duration (from incision to the last suture of the skin) was at least 2 hours.
Disqualifiers
Pregnant or lactating patients;
Patients diagnosed with septic shock or multiple organ failure within 14 days;
Patients with preoperative severe electrolyte disorders;
Patients with stroke, transient ischemic attack, or other similar events within the past 3 months
Trial design
Treatments tested in this trial
- oxycodone and parecoxib sodium combinations
- Placebo and parecoxib sodium combinations
Treatment groups
Locations
Sponsors and collaborators
Ailin Luo
Lead sponsor
Tongji Hospital
Sponsor institution
Jinhua Central Hospital
Collaborator
Minda Hospital of Hubei Minzu University
Collaborator
Taihe Hospital of Traditional Chinese Medicine
Collaborator
Qujing first people's Hospital
Collaborator